Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
To get full text for drug patents
— Researcher, Belarus
To get patent expiry dates for molecules in South Africa
— Operations manager, India
To find generic producers around the world for specific active ingredients.
— Pharmaceutical wholesaler, Estonia
To find expiring patents for generic product development
— Product manager, Saudi Arabia
To stay up to speed on latest developments
— VP product development, USA
Generated: May 25, 2017
What is the patent landscape for Caldolor, and what generic Caldolor alternatives are available?
Caldolor is a drug marketed by Cumberland Pharms and is included in one NDA. There are seven patents protecting this drug.| Patents: | 7 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: see list | 1 |
| Bulk Api Vendors: see list | 109 |
| Clinical Trials: see list | 10 |
| Patent Applications: see list | 9,521 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see details |
| DailyMed Link: | CALDOLOR at DailyMed |
| Ingredient-type | Nonsteroidal Anti-inflammatory Compounds |
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cumberland Pharms | CALDOLOR | ibuprofen | SOLUTION;INTRAVENOUS | 022348-001 | Jun 11, 2009 | DISCN | No | No | 6,727,286 | ► Subscribe | Y | ► Subscribe | |||||||||||||||||
Cumberland Pharms | CALDOLOR | ibuprofen | SOLUTION;INTRAVENOUS | 022348-002 | Jun 11, 2009 | RX | Yes | Yes | 9,012,508 | ► Subscribe | ► Subscribe | ||||||||||||||||||
Cumberland Pharms | CALDOLOR | ibuprofen | SOLUTION;INTRAVENOUS | 022348-002 | Jun 11, 2009 | RX | Yes | Yes | 9,138,404 | ► Subscribe | ► Subscribe | ||||||||||||||||||
Cumberland Pharms | CALDOLOR | ibuprofen | SOLUTION;INTRAVENOUS | 022348-002 | Jun 11, 2009 | RX | Yes | Yes | 9,295,639 | ► Subscribe | ► Subscribe | ||||||||||||||||||
Cumberland Pharms | CALDOLOR | ibuprofen | SOLUTION;INTRAVENOUS | 022348-002 | Jun 11, 2009 | RX | Yes | Yes | 6,727,286 | ► Subscribe | Y | ► Subscribe | |||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Expired Orange Book Patents
Available with subscription
Paragraph IV Activity
Available with subscription
Patent Maintenance
Available with subscription
Non-Orange Book Patents
Available with subscription
International Patents
Available with subscription
Supplementary Protection Certificates
Available with subscription
To get information on when drug patents are set to expire or have expired
— Journalist, UK
To follow up IP status of APIs in the Commonwealth of Independent States
— API wholesaler, UK
For patent related information to plan launch of generics worldwide
— Director, international business, India
For information on patent expirations
— Business development manager, Greece
To find generic producers around the world for specific active ingredients.
— Pharmaceutical wholesaler, Estonia
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
